Brief: Nippon Shinyaku Co Says Johnson & Johnson Obtains Approval Of Opsumit
22/12/2025 07:37
Dec 22 (Reuters) - Nippon Shinyaku Co Ltd 4516.T: NIPPON SHINYAKU CO: JOHNSON & JOHNSON OBTAINS APPROVAL OF OPSUMIT FOR TREATMENT OF PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN JAPAN Source text: [ID:] Further company coverage: 4516.T ((Reuters.Briefs@thomsonreuters.com;))